Skip to main content
logo
Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
86.93
0.00 (0.00%)
Apr 21, 2026, 10:45 AM EDT - Market open

Kymera Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
7,0976,3282,6111,4151,3743,272
Market Cap Growth
314.57%142.39%84.46%3.02%-58.01%18.64%
Enterprise Value
5,5605,5482,1961,119980.012,844
Last Close Price
86.9377.8140.2325.4624.9663.49
PE Ratio
--21.09-13.50-10.10-8.70-30.38
PS Ratio
181.00161.3855.4618.0129.3444.93
PB Ratio
4.484.013.123.582.807.12
P/TBV Ratio
4.654.163.613.762.756.63
P/FCF Ratio
--27.00-12.59-10.31-8.81-25.06
P/OCF Ratio
--27.17-13.42-13.76-8.97-25.38
EV/Sales Ratio
141.80141.4946.6614.2320.9339.05
EV/EBITDA Ratio
--16.27-8.64-6.91-6.19-28.98
EV/EBIT Ratio
--15.88-8.40-6.76-6.08-28.29
EV/FCF Ratio
--23.67-10.59-8.15-6.29-21.79
Debt / Equity Ratio
0.040.040.090.200.030.03
Debt / EBITDA Ratio
-0.24-0.24-0.34-0.52-0.11-0.18
Debt / FCF Ratio
-0.35-0.35-0.42-0.62-0.11-0.14
Net Debt / Equity Ratio
-0.48-0.48-0.48-0.73-0.79-0.92
Net Debt / EBITDA Ratio
2.252.251.581.792.464.33
Net Debt / FCF Ratio
3.273.271.932.112.503.25
Asset Turnover
0.030.030.060.130.080.13
Quick Ratio
10.1910.197.214.595.744.78
Current Ratio
10.4710.477.534.735.884.88
Return on Equity (ROE)
-25.78%-25.78%-36.38%-33.21%-32.60%-26.96%
Return on Assets (ROA)
-25.68%-25.68%-33.68%-28.08%-26.68%-18.39%
Return on Invested Capital (ROIC)
-53.89%-53.89%-86.01%-102.16%-107.27%-64.28%
Return on Capital Employed (ROCE)
-27.19%-27.19%-37.37%-32.40%-30.86%-22.59%
Earnings Yield
-4.39%-4.74%-7.41%-9.90%-11.50%-3.29%
FCF Yield
-3.30%-3.70%-7.94%-9.70%-11.35%-3.99%
Buyback Yield / Dilution
-12.59%-12.59%-28.58%-8.22%-12.39%-176.60%
Total Shareholder Return
-12.59%-12.59%-28.58%-8.22%-12.39%-176.60%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q